Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H11NO2 |
| Molecular Weight | 153.1784 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)COC(=O)C(=C)C#N
InChI
InChIKey=QRWOVIRDHQJFDB-UHFFFAOYSA-N
InChI=1S/C8H11NO2/c1-6(2)5-11-8(10)7(3)4-9/h6H,3,5H2,1-2H3
| Molecular Formula | C8H11NO2 |
| Molecular Weight | 153.1784 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Bucrylate (isobutyl cyanoacrylate) is a liquid tissue adhesive for transcatheter embolization. It is used in radiological and endoscopic interventions to occlude vessels and to stop bleedings. In comparison with sponges, coils and plugs, bucrylate is inexpensive and achieves immediate, irreversible and complete occlusion of the vessel irrespective of coagulation deficiencies.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Secondary cytotoxicity mediated by alveolar macrophages: a contribution to the total efficacy of nanoparticles in lung cancer therapy? | 2010-09 |
|
| Spontaneous rupture of a giant hepatic hemangioma - sequential management with transcatheter arterial embolization and resection. | 2010-03-27 |
|
| Perfusion computed tomography in a dural arteriovenous fistula presenting with focal signs: vascular congestion as a cause of reversible neurologic dysfunction. | 2010-01 |
|
| Evaluation of therapeutic effects and serious complications following endoscopic obliterative therapy with Histoacryl. | 2010 |
|
| Editorial comment on: Reducing laparoscopic radical prostatectomy false-positive margin rates using cyanoacrylate tissue glue. | 2009-10 |
|
| Editorial comment on: Reducing laparoscopic radical prostatectomy false-positive margin rates using cyanoacrylate tissue glue. | 2009-10 |
|
| Reducing laparoscopic radical prostatectomy false-positive margin rates using cyanoacrylate tissue glue. | 2009-10 |
|
| [Case of repeated hemoptysis successfully treated with bronchial artery embolization with N-butyl cyanoacrylate]. | 2009-05 |
|
| Percutaneous injection of hemostatic agents for severe blunt hepatic trauma: an experimental study. | 2008-12 |
|
| Percutaneous transportal sclerotherapy with N-butyl-2-cyanoacrylate for gastric varices: technique and clinical efficacy. | 2008-11-29 |
|
| Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol embolization. | 2008-06-06 |
|
| In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles. | 2007-06-29 |
|
| Transcatheter arterial embolization of nonvariceal upper gastrointestinal bleeding with N-butyl cyanoacrylate. | 2007-02-06 |
|
| Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles. | 2007-02 |
|
| Embolisation of proximal anastomotic pseudoaneurysm developing after surgical repair of abdominal aortic aneurysm with a bifurcated graft with n-butyl cyanoacrylate. | 2006-12 |
|
| Percutaneous protective coil occlusion of the proximal inferior mesenteric artery before N-butyl cyanoacrylate embolization of type II endoleaks after endovascular repair of abdominal aortic aneurysms. | 2006-11 |
|
| Busulfan loading into poly(alkyl cyanoacrylate) nanoparticles: physico-chemistry and molecular modeling. | 2006-11 |
|
| Embolization of an aortic arch pseudoaneurysm with coils and N-butyl-cyanoacrylate. | 2006-10 |
|
| Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles. | 2006-07-15 |
|
| Endovascular treatment of arterial injury as an uncommon complication after orthopedic surgery. | 2006-05 |
|
| Estimation of the remaining periodontal ligament from attachment-level measurements. | 2006-03 |
|
| Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: a histopathological follow-up. | 2006-02 |
|
| The effectiveness of isobutyl cyanoacrylate tissue adhesive for the treatment of corneal perforations. | 2005-11 |
|
| Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. | 2005-11 |
|
| Controlled myocardial infarction induced by intracoronary injection of n-butyl cyanoacrylatein dogs: a feasibility study. | 2005-10 |
|
| The use of isobutylcyanoacrylate as a tissue adhesive in abdominal surgery. | 2005-08 |
|
| Embolization of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms with use of cyanoacrylate with or without coils. | 2005-06 |
|
| A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles. | 2005-06 |
|
| Physical and biological properties of a novel siloxane adhesive for soft tissue applications. | 2005 |
|
| Intra-arterial hepatic chemotherapy: management of liver tumors by percutaneous port-a-cath positioning. | 2003-12 |
|
| Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. | 2003-11 |
|
| Treatment of a primary type IA endoleak with a liquid embolic system under conditions of aortic occlusion. | 2003-02 |
|
| Scaffold-enhanced albumin and n-butyl-cyanoacrylate adhesives for tissue repair: ex vivo evaluation in a porcine model. | 2003 |
|
| Laser disintegration of cyanoacrylate clot with successful endoscopic removal of sclerotherapy needle from gastric varix. | 2002-08 |
|
| Cyanoacrylate tissue adhesive for treatment of refractory corneal ulceration. | 2002-03 |
|
| Endoscopic repair of bronchial dehiscence after lung transplantation. | 2001-12 |
|
| Use of Indermil tissue adhesive for closure of superficial skin lacerations in children. | 2001-08 |
|
| Use of isobutyl cyanoacrylate tissue adhesive to stabilize external eyelid weights in temporary treatment of facial palsies. | 2001-05 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:40 GMT 2025
by
admin
on
Mon Mar 31 17:50:40 GMT 2025
|
| Record UNII |
2HJV1F859Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2103950
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
2755
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
2HJV1F859Z
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
C171658
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
100000088432
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
m6455
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | Merck Index | ||
|
213-958-1
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
D002015
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
1069-55-2
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
DTXSID1061447
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
Isobutyl cyanoacrylate
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
14046
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY | |||
|
SUB05952MIG
Created by
admin on Mon Mar 31 17:50:40 GMT 2025 , Edited by admin on Mon Mar 31 17:50:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |